Search results for:
	vaccinia immune globulin, human
 
	vaccinia immune globulin, human
	
	
	
			
			
				
					| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange | 
				
				
					
						
							| VIGIV, CNJ-016 | SOLUTION, INTRAVENOUS | 5% or 50 mg/mL |  |  |  |  | 
																		
		 
	 
			
		
						
							
		
	
	
	
			
		
		
	
	
		Last updated: Oct. 10, 2022	
	
	
	
	
	
			
		
		
	
	
	
	
			
 
         
                  
        
                  	
              
Restricted to use by infectious diseases prescribers per CDC guidelines.
Reviewed: Sept. 2022 (VIGIV, CNJ-106)